【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, January 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, January 2013 9
2.2.1 MacroGenics Enters into Licensing Agreement with Gilead Sciences for DART Technology 9
2.2.2 Highmark to Acquire West Penn Allegheny Health System for $1.1 Billion 9
2.2.3 Allergan Commences Tender Offer to Acquire MAP Pharma, Migraine Drug Maker, for $958 Million 10
2.2.4 Tenet Healthcare Completed Private Placement of Notes Due 2021 for $850 Million 10
2.2.5 Baxter International to Acquire Rights to Hemophilia Compound OBI-1 and Related Assets for $700 Million 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, January 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, January 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, January 2013 14
3.1.1 Top M&A Deals in January 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, August 2012–January 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, January 2013 17
3.2.1 Top Equity Offering Deals in January 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, August 2012 – January 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, January 2013 20
3.3.1 Top PE/VC Deals in January 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, January 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, January 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, August 2012 – January 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, August 2012 – January 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, January 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, January 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, August 2012 – January 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), January 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, January 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2012 – January 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number of Deals, August 2012 – January 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), August 2012 – January 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), August 2012 – January 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, January 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, January 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), January 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, January 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, January 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, January 2013 37
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), August 2012 – January 2013 38
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), August 2012 – January 2013 39
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), August 2012 – January 2013 40
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), August 2012 – January 2013 42
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 43
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, January 2013 43
6.1.1 Oncology – Deals of the Month 44
6.2 Pharmaceuticals & Healthcare, Global, Immunology Deals, January 2013 45
6.2.1 Immunology – Deal of the Month 46
6.3 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, January 2013 47
6.3.1 Central Nervous System – Deals of the Month 48
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, January 2013 49
6.4.1 Metabolic Disorders – Deal of the Month 50
6.5 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, January 2013 51
6.5.1 Infectious Diseases – Deals of the Month 52
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, January 2013 53
6.6.1 Cardiovascular – Deal of the Month 54
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, January 2013 55
6.7.1 Gastrointestinal – Deals of the Month 56
7 Deal Summary by Geography 57
7.1 Pharmaceuticals & Healthcare, North America Deals, January 2013 57
7.1.1 North America – Deals of the Month 58
7.2 Pharmaceuticals & Healthcare, Europe, Deals, January 2013 60
7.2.1 Europe – Deals of the Month 61
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, January 2013 62
7.3.1 Asia-Pacific – Deals of the Month 63
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, January 2013 64
7.4.1 Rest of the World – Deals of the Month 65
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 66
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, August 2012 – January 2013 66
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, August 2012 – January 2013 67
9 Further Information 68
9.1 Methodology 68
9.2 About GlobalData 69
9.3 Contact Us 69
9.4 Disclosure information 69
9.5 Disclaimer 69
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：January 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals
■ 発行日：2013年2月25日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160452
■ 調査対象地域：グローバル
- グローバル・エンジニアリングサービス市場動向（2014-2018）About Engineering Services Engineering services include design services for building and infrastructure projects, design services for industrial processes and industrial equipment, design services for environmental projects, construction management of projects, and asset management and operation of industrial processes. Vendors in the Global Engineering Services market provide technical services f …
- オフショア係留システムの世界市場分析：タイプ別（スプレッド、SPM、ダイナミック・ポジショニング、テンドン）、用途別（TLP、半潜水艦、SPAR、FPSO、ドリル船）、足場別、セグメント予測、2014-2025The global offshore mooring systems market is expected to reach USD 1.32 billion by 2025, according to a new report by Grand View Research, Inc. Increasing oil and gas production and exploration from the offshore fields rather than the onshore and the rising development of shale drilling regions for sustainable growth in future is expected to drive the demand for offshore mooring market. Innovatio …
- 乗用車用セキュリティ装置の世界市場：イモビライザー、カーアラーム、セントラルロッキングシステム、リモートキーレスエントリー（RKE）About Passenger Car Security Systems With an increase in the production and sales of vehicles worldwide, instances of car theft or hijacking are on the rise. Passenger car security products such as immobilizers, alarms, central locking systems, and RKE protect cars from theft or hijacking. These passenger car security products immediately alert the owner and the SOCs in cases of theft. Technologie …
- 萎縮性胃炎(Atrophic Gastritis)：世界の治験レビュー（2015年上半期版）Atrophic Gastritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Atrophic Gastritis Global Clinical Trials Review, H1, 2015" provides data on the Atrophic Gastritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrophic Gastritis. It includes an overview of the trial numbers and their recruitme …
- 産業用パネルコンピュータの世界市場ABSTRACTAbout Industrial Panel PC Industrial panel PCs are incorporated with an LCD, motherboard, and other electronic components in the same enclosure. These panel PCs assimilate touchscreens for user interaction. They are used in manufacturing and non-manufacturing industries. These panel PCs are used in automation systems integration, smart buildings, process and discrete manufacturing, HMI, sm …
- 世界の無線通信端末用半導体市場：Global Semiconductors for Wireless Communication Devices Market 2012-2016TechNavio's analysts forecast the Global Semiconductors for Wireless Communication Devices market to grow at a CAGR of 8 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high adoption of mobile phones expected during the forecast period. The Global Semiconductors for Wireless Communication Devices market has also been witnessing a continual increa …
- ビジネス情報サービスの世界市場2015-2019About Business Information Business information services provide various forms of content including information on M&A; news; market research; financial, legal, marketing, and credit information; and healthcare and current awareness news. These services are offered by business information providers on a subscription basis for a monthly or yearly fee. Business professionals rely on business informa …
- 世界のビジネス・インテリジェンス（BIソリューション）市場In today’s business environments, organizations have to utilize their fullest potential to continuously improve themselves in competitiveness and in performance management to sustain. Business Intelligence is concerned with the analysis of data to improve the organizational performance and to increase the profits and competitiveness of the organization. With increasing volume of the data to be pro …
- Non-Hodgkin Lymphoma：グローバル臨床試験レビューH2, 2013Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Hodgkin Lymphoma. It includes an overview of the trial numbers and their r …
- 公共安全LTE装置の世界市場2015-2019About Public Safety LTE Safety and security are critical to any country's prosperity. Public safety involves the critical process of communicating right information at the right time. This can be achieved by using LTE, which is a transformation technology. Public safety LTE is the introduction of next-generation wireless broadband technology in the mission-critical field applications, equipping pe …
- ブレーキ装置の世界市場：用途（乗用車、商用車、オフハイウェイ車両、ワゴン、機関車、RTV）、種類（ディスクブレーキ、ドラムブレーキ）、技術（ABS、TCS、ESC、EBD）Asia-Oceania is estimated to dominate the brake system market for automotive. The growth can be majorly attributed to the increasing demand of vehicles across the region. As of 2015, China and Japan are estimated to lead the brake system market for automotive in the region, whereas the Indian brake system market for automotive is projected to be one of the fastest growing markets. This growth can …
- 髄膜炎検査の世界市場2015The report presents a detailed analysis of the Meningitis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Meningitis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals & …
- ポリエーテルアミンの世界市場予測（～2022年）：モノアミン、ジアミン、トリアミンThe global polyetheramine market is projected to reach USD 1,074.0 Million by 2022, at a CAGR of 9.3% from 2017 to 2022. The growing use of polyetheramine in different applications such as epoxy coatings, composites, polyurea, and adhesives & sealants for construction and wind energy industry is driving the market for polyetheramine. The use of polyetheramine-based composites in the wind energy in …
- 酸化亜鉛の世界市場予測（～2024年）“The large-scale and growing demand from rubber application is driving the market, globally.” The global zinc oxide market size is estimated to grow from USD 4.4 billion in 2019 and to USD 5.7 billion by 2024, at a CAGR of 5.4% during the forecast period. The market is driven by the large-scale and growing use of zinc oxide (ZnO) in application areas such as rubber and ceramics manufacturing. The …
- 世界のEPOバイオシミラー（Erythropoietin Biosimilars）市場展望2018The biosimilars industry has been growing stupendously across the globe for the past few years. Increasing healthcare costs, major blockbuster drugs about to go off patent and rising aging population are driving this industry, which stands at a vivid position, and is expected to evolve greatly from its current state. With the governments and private players worldwide stepping into this industry, t …
